Literature DB >> 21735406

Tight control of mild-moderate pre-existing or non-proteinuric gestational hypertension.

Ashraf F Nabhan1, Maged M Elsedawy.   

Abstract

BACKGROUND: The question of the target blood pressure in pregnant women with mild-moderate hypertension continues to be an area of debate.
OBJECTIVES: To compare tight versus very tight control of mild-moderate pre-existing or non-proteinuric gestational hypertension for improving outcomes SEARCH STRATEGY: We searched the Cochrane Pregnancy and Childbirth Group's Trials Register (31 March 2011), CENTRAL (The Cochrane Library 2011, Issue 3), MEDLINE (January 1966 to March 2011), and the metaRegister of Controlled Trials (31 March 2011). We handsearched citation lists of relevant publications, review articles, and included studies. SELECTION CRITERIA: Randomized controlled trials of tight versus very tight control in pregnant women with mild or moderate pre-existing or non-proteinuric gestational hypertension. DATA COLLECTION AND ANALYSIS: Two authors independently assessed trial quality and extracted data. We expressed results as risk ratio (RR) or mean differences, together with their 95% confidence intervals (CI). MAIN
RESULTS: We included two studies (256 participants) with mild-moderate pre-existing or non-proteinuric gestational hypertension. There was no evidence of a difference between tight and very tight control groups regarding severe pre-eclampsia (risk ratio (RR) 1.28, 95% CI 0.97 to 1.70; two trials, 256 participants). More women in the tight group were hospitalized during their pregnancy (RR 2.53, 95% CI 1.14 to 5.63; one trial, 125 participants). There was no evidence of a difference in other outcome measures including fetal distress, IUGR, neonatal admission to a NICU, perinatal deaths, induction of labor and cesarean delivery between the tight and the very tight control groups. Gestational age at delivery had a non-significant mean difference (MD) of -0.15 weeks between the tight and very tight control groups (MD -0.15, 95% CI -1.52 to 1.21, random-effects, T² = 0.75, I² = 77%; two trials, 256 participants). The MD in birthweight between the tight and the very tight control group was not significant (MD -100.00 grams, 95% CI -363.69 to 163.69; one trial, 125 participants). AUTHORS'
CONCLUSIONS: For pregnant women with non-severe pre-existing or non-proteinuric gestational hypertension, there is insufficient evidence to determine how tight control of hypertension should be achieved to improve maternal and fetal-neonatal outcomes.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21735406     DOI: 10.1002/14651858.CD006907.pub2

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN: 1361-6137


  8 in total

1.  Hypertensive disorders in pregnancy.

Authors:  Wilbert S Aronow
Journal:  Ann Transl Med       Date:  2017-06

2.  Reducing stillbirths: prevention and management of medical disorders and infections during pregnancy.

Authors:  Esme V Menezes; Mohammad Yawar Yakoob; Tanya Soomro; Rachel A Haws; Gary L Darmstadt; Zulfiqar A Bhutta
Journal:  BMC Pregnancy Childbirth       Date:  2009-05-07       Impact factor: 3.007

3.  NFKB1-mediated downregulation of microRNA-106a promotes oxidative stress injury and insulin resistance in mice with gestational hypertension.

Authors:  Yunxia Guo; Zhaofang Liu; Ming Wang
Journal:  Cytotechnology       Date:  2021-01-04       Impact factor: 2.058

4.  Dichotomisation of a continuous outcome and effect on meta-analyses: illustration of the distributional approach using the outcome birthweight.

Authors:  Mercy Ofuya; Odile Sauzet; Janet L Peacock
Journal:  Syst Rev       Date:  2014-06-12

Review 5.  A best practice position statement on pregnancy in chronic kidney disease: the Italian Study Group on Kidney and Pregnancy.

Authors:  Gianfranca Cabiddu; Santina Castellino; Giuseppe Gernone; Domenico Santoro; Gabriella Moroni; Michele Giannattasio; Gina Gregorini; Franca Giacchino; Rossella Attini; Valentina Loi; Monica Limardo; Linda Gammaro; Tullia Todros; Giorgina Barbara Piccoli
Journal:  J Nephrol       Date:  2016-03-17       Impact factor: 3.902

Review 6.  A best-practice position statement on pregnancy after kidney transplantation: focusing on the unsolved questions. The Kidney and Pregnancy Study Group of the Italian Society of Nephrology.

Authors:  Gianfranca Cabiddu; Donatella Spotti; Giuseppe Gernone; Domenico Santoro; Gabriella Moroni; Gina Gregorini; Franca Giacchino; Rossella Attini; Monica Limardo; Linda Gammaro; Tullia Todros; Giorgina Barbara Piccoli
Journal:  J Nephrol       Date:  2018-06-14       Impact factor: 3.902

Review 7.  Cardio-Obstetrics: the Next Frontier in Cardiovascular Disease Prevention.

Authors:  Aarti Thakkar; Tigist Hailu; Roger S Blumenthal; Seth S Martin; Colleen M Harrington; Doreen DeFaria Yeh; Katharine A French; Garima Sharma
Journal:  Curr Atheroscler Rep       Date:  2022-05-07       Impact factor: 5.967

Review 8.  Interventions to improve safe and effective medicines use by consumers: an overview of systematic reviews.

Authors:  Rebecca Ryan; Nancy Santesso; Dianne Lowe; Sophie Hill; Jeremy Grimshaw; Megan Prictor; Caroline Kaufman; Genevieve Cowie; Michael Taylor
Journal:  Cochrane Database Syst Rev       Date:  2014-04-29
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.